It is a regulatory, commercial and relationship problem. We handle all three — from entry strategy and the right local partner, through registration, to the first customers and the growth that follows.
Most entries into Brazil do not fail at registration. They fail at step two — the wrong partner, signed too early, in a market where distribution is regional and fragmented.
Brazil is the largest healthcare market in Latin America and one of the hardest to enter well. Three failures account for most of it.
A distributor that looks national on paper often covers three states in practice. Customer relationships, hospital contracts and working capital vary enormously between regions — and none of that shows up in a company profile.
Classification, the local registration holder and the structure of your portfolio all constrain what you can sell, to whom, and how fast you can add a new item. Decided by regulatory alone, it boxes in the commercial plan for years.
Contracts get signed and the manufacturer goes quiet. But adoption in Brazil is won account by account: hospital purchasing approval, product in the right place at the right time, a trained team in the room, and support on the first cases.
We work as your commercial team in Brazil until you have a reason to build your own — and as your partner after that.
Realistic sizing by segment and channel, pricing and reimbursement conditions, competitive mapping, and a recommendation on the entry model: direct, distributor, exclusive master, or a hybrid.
We shortlist, approach and qualify distributors and local structures against your product, then support negotiation, terms and the commercial agreement. We know the field because we have worked inside it.
Launch planning, pricing tables, sales team training, key opinion leader engagement, hospital and public channel approvals, and presence in the first cases. The part that turns a signed agreement into revenue.
Ongoing commercial management: account expansion, new regions, additional product lines, private and public channel strategy, and periodic reporting back to your headquarters.
Three steps, in order. You will know early whether Brazil is worth the investment, and what it would take.
You describe the product, the registration status and what you have tried so far. We tell you honestly whether we are the right fit and what the realistic obstacles look like.
A written picture of the opportunity and what stands in the way: market and competition, channel recommendation, a shortlist of qualified partners, and the timeline each option requires.
We run the plan: partner negotiation, launch, training, first accounts and continuous commercial management, reporting to you on an agreed cadence.
Every project is staffed with senior people who have run this market from the inside — former executives of multinational healthcare companies, not junior consultants learning on your account.
Commercial leadership on both sides of the table: at multinational manufacturers, including Stryker and LivaNova, and at premium healthcare distributors in Brazil.
Has led pricing negotiations, hospital and distributor contracts, product launches and market expansion across the private and public channels.
LinkedIn profileWe assemble each engagement from a network of senior professionals who have held executive roles at multinational healthcare companies in Brazil. Depending on what your project needs, that includes:
A sample of what the work looks like in practice. Client names are confidential and shared on request where permitted.
Market entry for a neurostimulation platform. Supported an Asian manufacturer bringing a nerve stimulation system into Brazil: market assessment, channel model, local partner structure and a commercial plan for a therapy adopted case by case.
Building a spine line in the Brazilian market. Engaged by a global manufacturer to develop its spine portfolio in Brazil from the ground up: positioning against established competitors, partner strategy, pricing and the commercial plan to reach reference surgeons.
Brazil market development for a surgical products manufacturer. Entry strategy and growth plan covering registration sequencing, channel design across private hospitals and the public system, and the local structure required to support it.
Opening a new country for a spine line. Helped a distributor start a spine operation from zero: portfolio definition, inventory dimensioning, pricing, surgeon engagement and the commercial routine to sustain it.
Commercial management for manufacturers and distributors. Continuous management of sales strategy, pricing and partner relationships across neurosurgery, orthopedics, capital equipment and consumables in Brazil.
Tell us about the product and where you are today. We reply within two business days, in English, Portuguese or Spanish.